Cargando…
Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
Purpose: To assess the clinical value of FDG PET/CT and evaluate the complementary roles of serum squamous cell carcinoma antigen (SCCAg) and FDG PET/CT in the diagnosis of suspected recurrent of cervical squamous cell cancer. Methods: Serum SCCAg levels were retrospectively reviewed in patients pre...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317765/ https://www.ncbi.nlm.nih.gov/pubmed/25663947 http://dx.doi.org/10.7150/jca.10819 |
_version_ | 1782355725667794944 |
---|---|
author | Hu, Ying-Ying Fan, Wei Zhang, Xu Liang, Pei-Yan Lin, Xiao-Ping Zhang, Ya-Rui Li, Yuan-Hua |
author_facet | Hu, Ying-Ying Fan, Wei Zhang, Xu Liang, Pei-Yan Lin, Xiao-Ping Zhang, Ya-Rui Li, Yuan-Hua |
author_sort | Hu, Ying-Ying |
collection | PubMed |
description | Purpose: To assess the clinical value of FDG PET/CT and evaluate the complementary roles of serum squamous cell carcinoma antigen (SCCAg) and FDG PET/CT in the diagnosis of suspected recurrent of cervical squamous cell cancer. Methods: Serum SCCAg levels were retrospectively reviewed in patients previously treated for cervical squamous cell carcinoma, who had suspected recurrence of cervical cancer and who had undergone FDG PET/CT scans. The clinical impact of elevated SCCAg (>1.5 ng/ml) and negative SCCAg (≤1.5 ng/ml) levels were analyzed based on the results of PET/CT and final diagnosis. Results: The overall patient-based sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT for the detection of tumor recurrence or malignancy were 100% (86/86), 80.8% (21/26), 95.5% (107/112), 94.5% (86/91) and 100% (21/21), respectively. Of the 112 patients included in this study, recurrence or malignancy was detected by PET/CT in 62 of the 64 patients with elevated SCCAg, compared to 24 of the 48 patients with negative SCCAg levels. The overall patient-based PPV, NPV, sensitivity and accuracy of SCCAg for the detection of tumor recurrence or malignancy were 96.9% (62/64), 50% (24/48), 72.1% (62/86) and 76.8% (86/112), respectively. The five false-positive PET/CT results were all associated with patients with negative SCCAg levels. The PPV of positive PET/CT-associated elevated SCCAg for the detection of tumor recurrence or malignancy was 100% (62/62). The NPV of negative SCCAg-associated negative PET/CT was 100% (19/19). Conclusions: Serum SCCAg evaluation and FDG PET/CT imaging can be complementary techniques in cases of suspected recurrent cervical squamous cancer. Positive PET/CT with elevated SCCAg can predict recurrence. Although PET/CT cannot confidently be deferred due to a negative SCCAg test, the possibility of a false-positive PET/CT in those cases may have diagnostic importance. |
format | Online Article Text |
id | pubmed-4317765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-43177652015-02-06 Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer Hu, Ying-Ying Fan, Wei Zhang, Xu Liang, Pei-Yan Lin, Xiao-Ping Zhang, Ya-Rui Li, Yuan-Hua J Cancer Research Paper Purpose: To assess the clinical value of FDG PET/CT and evaluate the complementary roles of serum squamous cell carcinoma antigen (SCCAg) and FDG PET/CT in the diagnosis of suspected recurrent of cervical squamous cell cancer. Methods: Serum SCCAg levels were retrospectively reviewed in patients previously treated for cervical squamous cell carcinoma, who had suspected recurrence of cervical cancer and who had undergone FDG PET/CT scans. The clinical impact of elevated SCCAg (>1.5 ng/ml) and negative SCCAg (≤1.5 ng/ml) levels were analyzed based on the results of PET/CT and final diagnosis. Results: The overall patient-based sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of PET/CT for the detection of tumor recurrence or malignancy were 100% (86/86), 80.8% (21/26), 95.5% (107/112), 94.5% (86/91) and 100% (21/21), respectively. Of the 112 patients included in this study, recurrence or malignancy was detected by PET/CT in 62 of the 64 patients with elevated SCCAg, compared to 24 of the 48 patients with negative SCCAg levels. The overall patient-based PPV, NPV, sensitivity and accuracy of SCCAg for the detection of tumor recurrence or malignancy were 96.9% (62/64), 50% (24/48), 72.1% (62/86) and 76.8% (86/112), respectively. The five false-positive PET/CT results were all associated with patients with negative SCCAg levels. The PPV of positive PET/CT-associated elevated SCCAg for the detection of tumor recurrence or malignancy was 100% (62/62). The NPV of negative SCCAg-associated negative PET/CT was 100% (19/19). Conclusions: Serum SCCAg evaluation and FDG PET/CT imaging can be complementary techniques in cases of suspected recurrent cervical squamous cancer. Positive PET/CT with elevated SCCAg can predict recurrence. Although PET/CT cannot confidently be deferred due to a negative SCCAg test, the possibility of a false-positive PET/CT in those cases may have diagnostic importance. Ivyspring International Publisher 2015-01-20 /pmc/articles/PMC4317765/ /pubmed/25663947 http://dx.doi.org/10.7150/jca.10819 Text en © 2015 Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. |
spellingShingle | Research Paper Hu, Ying-Ying Fan, Wei Zhang, Xu Liang, Pei-Yan Lin, Xiao-Ping Zhang, Ya-Rui Li, Yuan-Hua Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer |
title | Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer |
title_full | Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer |
title_fullStr | Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer |
title_full_unstemmed | Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer |
title_short | Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer |
title_sort | complementary roles of squamous cell carcinoma antigen and (18)f-fdg pet/ct in suspected recurrence of cervical squamous cell cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317765/ https://www.ncbi.nlm.nih.gov/pubmed/25663947 http://dx.doi.org/10.7150/jca.10819 |
work_keys_str_mv | AT huyingying complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer AT fanwei complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer AT zhangxu complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer AT liangpeiyan complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer AT linxiaoping complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer AT zhangyarui complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer AT liyuanhua complementaryrolesofsquamouscellcarcinomaantigenand18ffdgpetctinsuspectedrecurrenceofcervicalsquamouscellcancer |